EFFECTS OF ETODOLAC ON METHOTREXATE (MTX) PHARMACOKINETICS IN RHEUMATOID-ARTHRITIS (RA) PATIENTS

被引：0
|
作者：
ANAYA, JM [1 ]
FABRE, D [1 ]
BRESSOLLE, F [1 ]
ALRIC, R [1 ]
DROPSY, R [1 ]
SANY, J [1 ]
机构：
[1] FAC PHARM MONTPELLIER,F-34060 MONTPELLIER,FRANCE
来源：
ARTHRITIS AND RHEUMATISM | 1992年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [41] METHOTREXATE (MTX) CONCENTRATIONS IN RED-BLOOD-CELLS (RBC) OF RHEUMATOID-ARTHRITIS (RA) PATIENTS - CORRELATIONS WITH IMMUNOLOGICAL PARAMETERS
    SPADARO, A
    RICCIERI, V
    SCAVALLI, AS
    TACCARI, E
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 124 - 124
  • [42] TUMOR-NECROSIS-FACTOR-ALPHA (TNF) BLOCKAGE ENHANCES METHOTREXATE (MTX) RESPONSE IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)
    SANDER, O
    HERBORN, G
    RAU, R
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 678 - 678
  • [43] EFFECT OF AGE, SEX AND SERUM CREATININE (CREAT) ON THE EFFICACY AND TOXICITY OF METHOTREXATE (MTX) IN RHEUMATOID-ARTHRITIS (RA)
    FELSON, D
    CHERNOFF, M
    WANG, MZ
    ANDERSON, J
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S77 - S77
  • [44] REDUCTION OF POLYAMINE (PA) LEVELS BY LOW-DOSE METHOTREXATE (MTX) THERAPY IN RHEUMATOID-ARTHRITIS (RA)
    MCKENDRY, RJR
    DALE, P
    OLIVERIS, L
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : R36 - R36
  • [45] Folic acid alters methotrexate (MTX) disposition in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Pouly, B
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S76 - S76
  • [46] SUSTAINED EFFICACY OF ADALIMUMAB (HUMIRA®) PLUS METHOTREXATE (MTX) IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Schiff, M. H.
    Weisman, M.
    Furst, D. E.
    Kavanaugh, A.
    Spencer-Green, G.
    Segurado, O. G.
    [J]. RHEUMATOLOGY, 2004, 43 : 40 - 40
  • [47] EFFECT OF ETODOLAC (ULTRADOL) AND ASPIRIN ON LYMPHOCYTE SUBPOPULATIONS IN RHEUMATOID-ARTHRITIS (RA)
    SPENCERGREEN, G
    ELRAMAHI, K
    HURTUBISE, P
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A513 - A513
  • [48] TOLERANCE AND EFFICACY OF METHOTREXATE (MTX) AS FIRST DISEASE-MODIFYING AGENT DURING RHEUMATOID-ARTHRITIS (RA)
    BOLOGNA, C
    VIU, P
    JORGENSEN, C
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1451 - 1451
  • [49] PHARMACOKINETICS OF METHOTREXATE ADMINISTERED BY INTRAMUSCULAR AND SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    BROOKS, PJ
    SPRUILL, WJ
    PARISH, RC
    BIRCHMORE, DA
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (01): : 91 - 94
  • [50] CORRELATION OF CLINICAL AND LABORATORY PARAMETERS WITH PHARMACOKINETIC (PK) MEASUREMENTS IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) ON METHOTREXATE (MTX) - A PROSPECTIVE-STUDY
    KREMER, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S143 - S143
12345